معرفی
Enikö Sonkoly is an active Senior Lecturer (Docent) and research group leader at the Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. Her work centers on molecular mechanisms in inflammatory skin diseases and skin cancer, with primary affiliations to the Division of Dermatology and Venereology and ongoing collaborations across European and international institutions.
Her research interests include:
- Dermatology (psoriasis, atopic dermatitis, skin cancer)
- Non-coding RNA biology (microRNAs, long non-coding RNAs)
- Epidermal barrier function and dysregulation
- Keratinocyte-immune system interactions
- Wound healing and inflammation
- Transcriptomic analysis of skin diseases
She has pioneered studies on RNA signatures in psoriasis keratinocytes, identified tumor-suppressive miRNAs in cutaneous squamous cell carcinoma, and explored chromatin dynamics in skin inflammation. Recent work leverages single-cell sequencing to map cellular interactions in psoriasis while investigating clinical implications of biologics through trials like VOYAGE 2.
Publication trends (2022-2025) highlight three key directions: (1) Functional characterization of specific non-coding RNAs (e.g., CYDAER, LINC00958) in epidermal dysregulation, (2) Clinical translation of RNA findings through biologics trials and registry studies, and (3) Integration of single-cell genomics with inflammation pathways. Her group consistently bridges molecular mechanisms and clinical dermatology.
Scientific awards:
- No awards, prizes, or fellowships are documented in the provided text.
Advising and grants:
Dr. Sonkoly supervises doctoral students Jan Cedric Freisenhausen (thesis 2025) and Longlong Luo (thesis 2023), with Luo also listed as affiliated staff. Her group includes Lars Norlen (Docent) and international collaborators. The text provides no grant details, funding sources, or project-specific financial information.
Labs and teams:
She heads the Research group Enikö Sonkoly at Karolinska Institutet, focusing on RNA mechanisms in skin diseases. The group utilizes next-generation sequencing, single-cell analysis, and functional assays to study keratinocyte biology within a multidisciplinary framework that includes clinical dermatology, immunology, and molecular oncology components.
